People: Cerus Corp (CERS.OQ)
Mr. Daniel N. Swisher, Jr., is an Independent Chairman of the Board of Cerus Corporation. Mr. Swisher has served as a member of our Board since June 2011 and has served as Chair of the Board since October 2013. Mr. Swisher has served as the President and Chief Operating Officer of Jazz Pharmaceuticals plc since January 2018. Prior to that, he served as the Chief Executive Officer of Sunesis Pharmaceuticals, Inc., or Sunesis, and a member of its board of directors from January 2004 through December 2017, and as its President since August 2005. From December 2001 to December 2003, he served as the Chief Business Officer and Chief Financial Officer of Sunesis. From June 1992 to September 2001, Mr. Swisher served in various management roles, including Senior Vice President of Sales and Marketing, for ALZA Corporation. He also serves on the board of directors of Corcept Therapeutics Incorporated, or Corcept Therapeutics, a pharmaceutical company. Mr. Swisher holds a B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business.
|Total Annual Compensation, USD||80,250|
|Restricted Stock Award, USD||86,372|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||86,374|
|Fiscal Year Total, USD||252,996|